STOCK TITAN

Expanding a Stroke Legacy: Terumo Neuro Announces US Commercial Availability of the SOFIA™ 88 Neurovascular Support Catheter

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Positive)
Tags

Terumo Neuro (TRUMY) has announced the US commercial launch of its SOFIA™ 88 Neurovascular Support Catheter, expanding its stroke treatment portfolio. The new catheter features an 0.088-inch inner diameter and builds upon the SOFIA™ Catheter line's decade-long legacy of supporting over 500,000 procedures across 170 countries.

The SOFIA™ 88 catheter offers key benefits including reliable trackability through challenging anatomy, proximal stability for procedural ease, and vessel-friendly flexibility. It is compatible with the SOFIA™ Flow Plus 6F Aspiration Catheter and integrates with Terumo's comprehensive stroke solution portfolio, which includes aspiration catheters, retrieval devices, balloon guide catheters, microcatheters, and guidewires.

Terumo Neuro (TRUMY) ha annunciato il lancio commerciale negli Stati Uniti del suo catetere di supporto neurovascolare SOFIA™ 88, ampliando così il proprio portafoglio di trattamenti per l'ictus. Il nuovo catetere presenta un diametro interno di 0,088 pollici e si basa sull'eredità decennale della linea di cateteri SOFIA™, che ha supportato oltre 500.000 procedure in 170 paesi.

Il catetere SOFIA™ 88 offre vantaggi chiave come un'affidabile capacità di avanzamento attraverso anatomie complesse, stabilità prossimale per facilitare le procedure e una flessibilità che rispetta i vasi sanguigni. È compatibile con il catetere di aspirazione SOFIA™ Flow Plus 6F e si integra con il portfolio completo di soluzioni per l'ictus di Terumo, che include cateteri di aspirazione, dispositivi di rimozione, cateteri guida a palloncino, microcateteri e guidewire.

Terumo Neuro (TRUMY) ha anunciado el lanzamiento comercial en EE. UU. de su catéter de soporte neurovascular SOFIA™ 88, ampliando su portafolio de tratamientos para el ictus. El nuevo catéter cuenta con un diámetro interno de 0,088 pulgadas y se basa en la trayectoria de una década de la línea de catéteres SOFIA™, que ha apoyado más de 500,000 procedimientos en 170 países.

El catéter SOFIA™ 88 ofrece beneficios clave como una trazabilidad confiable a través de anatomías complejas, estabilidad proximal para facilitar el procedimiento y flexibilidad amigable con los vasos. Es compatible con el catéter de aspiración SOFIA™ Flow Plus 6F e integra el portafolio integral de soluciones para ictus de Terumo, que incluye catéteres de aspiración, dispositivos de recuperación, catéteres guía con balón, microcatéteres y guías.

Terumo Neuro (TRUMY)는 미국에서 SOFIA™ 88 신경혈관 지원 카테터의 상업적 출시를 발표하며 뇌졸중 치료 포트폴리오를 확장했습니다. 새로운 카테터는 0.088인치 내경을 갖추고 있으며, 170개국에서 50만 건 이상의 시술을 지원해온 SOFIA™ 카테터 라인의 10년 전통을 기반으로 합니다.

SOFIA™ 88 카테터는 복잡한 해부학 구조에서도 신뢰할 수 있는 추적성, 시술의 용이성을 위한 근위 안정성, 혈관 친화적인 유연성 등의 주요 장점을 제공합니다. SOFIA™ Flow Plus 6F 흡인 카테터와 호환되며, 흡인 카테터, 회수 장치, 풍선 가이드 카테터, 마이크로카테터, 가이드와이어를 포함한 Terumo의 종합적인 뇌졸중 솔루션 포트폴리오와 통합됩니다.

Terumo Neuro (TRUMY) a annoncé le lancement commercial aux États-Unis de son cathéter de soutien neurovasculaire SOFIA™ 88, élargissant ainsi son portefeuille de traitements contre l’AVC. Ce nouveau cathéter dispose d’un diamètre interne de 0,088 pouce et s’appuie sur la longue expérience de la gamme de cathéters SOFIA™, qui a soutenu plus de 500 000 interventions dans 170 pays.

Le cathéter SOFIA™ 88 offre des avantages clés tels qu’une excellente maniabilité dans des anatomies complexes, une stabilité proximale facilitant la procédure et une flexibilité respectueuse des vaisseaux. Il est compatible avec le cathéter d’aspiration SOFIA™ Flow Plus 6F et s’intègre au portefeuille complet de solutions contre l’AVC de Terumo, comprenant des cathéters d’aspiration, des dispositifs de récupération, des cathéters guides à ballonnet, des microcathéters et des guides-fil.

Terumo Neuro (TRUMY) hat die kommerzielle Markteinführung seines SOFIA™ 88 Neurovaskulären Unterstützungskatheters in den USA bekannt gegeben und erweitert damit sein Portfolio zur Schlaganfallbehandlung. Der neue Katheter verfügt über einen Inneninnendurchmesser von 0,088 Zoll und baut auf der zehnjährigen Erfolgsgeschichte der SOFIA™ Katheterlinie auf, die weltweit bei über 500.000 Eingriffen in 170 Ländern zum Einsatz kam.

Der SOFIA™ 88 Katheter bietet wesentliche Vorteile wie zuverlässige Nachführbarkeit durch komplexe Anatomien, proximale Stabilität für eine einfache Handhabung und gefäßfreundliche Flexibilität. Er ist kompatibel mit dem SOFIA™ Flow Plus 6F Absaugkatheter und integriert sich in Terumos umfassendes Schlaganfall-Lösungsportfolio, das Absaugkatheter, Retrieval-Geräte, Ballon-Guide-Katheter, Mikrokatheter und Führungsdrähte umfasst.

Positive
  • Strong clinical legacy with SOFIA™ Catheter line used in over 500,000 procedures across 170 countries
  • Positive physician feedback highlighting improved access and first pass effect
  • Expanded product portfolio strengthening company's position in neurovascular market
  • Compatible with existing aspiration strategies and complementary products
Negative
  • None.

Terumo Neuro's SOFIA ™ Catheter Line is Backed By 10 Years of Proven Clinical Performance and Innovation – The New SOFIA™ 88 Catheter Offers Reliable Trackability, Proximal Stability and Vessel-Friendly Flexibility

ALISO VIEJO, Calif., May 13, 2025 /PRNewswire/ -- Terumo Neuro, a global leader in neurovascular innovation and a wholly owned subsidiary of Terumo Corporation, today announced the commercial availability of the SOFIA™ 88 Neurovascular Support Catheter, expanding the company's stroke portfolio with a new large-bore catheter engineered for reliability, procedural flexibility, and physician control. The launch builds on the proven clinical performance and global legacy of the SOFIA™ Catheter line, which has supported more than 500,000 procedures across 170 countries over the past decade.

Leveraging more than ten years of neurovascular catheter innovation, physician partnerships and proven clinical performance, the SOFIA™ 88 Neurovascular Support Catheter offers an 0.088-inch inner diameter with proprietary engineering enhancements designed to provide the following benefits:

  • Reach with Confidence – Reliable trackability through challenging anatomy via optimized transition zones and a soft, atraumatic distal tip.
  • Support to Go the Distance – Proximal stability for procedural ease with both short and long sheaths.
  • Atraumatic by Design – Flexibility and reinforcement throughout the entire working length to minimize vessel trauma and support smooth navigation.

"Terumo Neuro's SOFIA 88 Neurovascular Support Catheter is truly one of the best products in this category, especially when using a short 8F sheath," said Dr. Ameer Hassan, Head of Neuroscience Department at Valley Baptist, Professor of Neurology, University of Texas Rio Grande Valley. "It has great trackability and it is improving my access whether I decide to use it to support an aspiration only or a combination approach -- it really does improve my first pass effect."

"As we introduce the SOFIA™ 88 Neurovascular Support Catheter, we are building on a decade of performance that physicians around the world have come to trust," said Carsten Schroeder, President and CEO of Terumo Neuro. "This launch reflects our continued investment in neurovascular innovation, made possible through direct collaboration with physicians and our strong R&D and manufacturing capabilities. Together, we are delivering meaningful advancements in stroke care designed to improve outcomes for patients worldwide."

The SOFIA™ 88 Neurovascular Support Catheter is compatible with the SOFIA™ Flow Plus 6F Aspiration Catheter and supports integration into existing aspiration strategies. Clinical evidence from the SOFAST registry—evaluating the SOFIA™ Flow Plus 6F as a first-line approach—demonstrated strong results across speed, efficacy, and safety and overall clinical outcomes. 

The new SOFIA™ 88 Catheter also seamlessly complements the company's broader stroke solution portfolio, offering a fully integrated approach across aspiration, access, retrieval, and navigation:

  • SOFIA™ and SOFIA™ Flow Plus Aspiration Catheters – Renowned for trackability and clinical performance
  • ERIC™ Retrieval Device – Designed for thrombus control and procedural efficiency and versatility
  • BOBBY™ Balloon Guide Catheter – Reliable flow arrest with streamlined preparation, optimized compatibility and next-generation balloon technology
  • WEDGE™ Microcatheter – A navigation aid that minimizes ledge effect
  • HEADWAY™ Microcatheters – Low-profile outer diameter, providing versatility, reliability, and fast access
  • TRAXCESS™ Guidewires – Soft-tip design for challenging anatomies

About Terumo Neuro (Formerly MicroVention, Inc.)
We are in business to create and deliver Game-changing Impact™—innovations that redefine what is possible in neurovascular treatment to meaningfully advance both physician practice and patient outcomes. Founded in 1997 as MicroVention and acquired by Terumo Corporation in 2006, Terumo Neuro offers more than thirty products for the treatment of cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations. Headquartered in California, Terumo Neuro products are sold in more than seventy countries through a direct sales organization as well as strategic distribution partnerships. Manufacturing facilities are in Aliso Viejo, California, and San José, Costa Rica. For more information on Terumo Neuro, please visit www.terumoneuro.com.

About Terumo Corporation
Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for one hundred years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Media Contact:
Christine McCullough
Global Corporate Communications
Terumo Neuro
+1 714 206 9800
christine.mccullough@terumoneuro.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/expanding-a-stroke-legacy-terumo-neuro-announces-us-commercial-availability-of-the-sofia-88-neurovascular-support-catheter-302453832.html

SOURCE Terumo Neuro

FAQ

What are the key features of Terumo's new SOFIA™ 88 Neurovascular Support Catheter?

The SOFIA™ 88 features an 0.088-inch inner diameter, optimized transition zones, soft atraumatic distal tip, proximal stability, and vessel-friendly flexibility throughout the working length.

How many procedures has the SOFIA™ Catheter line supported globally?

The SOFIA™ Catheter line has supported more than 500,000 procedures across 170 countries over the past decade.

What products are included in Terumo's (TRUMY) stroke solution portfolio?

Terumo's portfolio includes SOFIA™ Aspiration Catheters, ERIC™ Retrieval Device, BOBBY™ Balloon Guide Catheter, WEDGE™ Microcatheter, HEADWAY™ Microcatheters, and TRAXCESS™ Guidewires.

Is the SOFIA™ 88 catheter compatible with other Terumo products?

Yes, the SOFIA™ 88 is compatible with the SOFIA™ Flow Plus 6F Aspiration Catheter and integrates with Terumo's broader stroke solution portfolio.
Terumo Corp

OTC:TRUMY

TRUMY Rankings

TRUMY Latest News

TRUMY Stock Data

27.54B
1.47B
0.02%
Medical Instruments & Supplies
Healthcare
Link
Japan
Tokyo